Forza Innovations Revenue per Share
Revenue per Share of Forza Innovations (FORZ) as of Nov 10, 2026.
Get this data via API
Financial Data API
Revenue per Share
0.00USD
YoY
89.03%
Last updated:
Revenue per Share of Forza Innovations is 2024 0.00 USD. Revenue per Share of Forza Innovations was 2023 0.00 USD. It decreases by 89.03% higher compared to the previous year.
The Forza Innovations Revenue per Share history
3 Years
10 Years
25 Years
Max
Revenue per Share
Date
Revenue per Share
Jan 1, 2017
0.00 USD
Jan 1, 2018
0.00 USD
Jan 1, 2019
0.00 USD
Jan 1, 2020
0.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
| YEAR | Revenue per Share | YoY |
|---|---|---|
| 0.00USD | +89.03% | |
| 0.00USD | +62.28% | |
| 0.00USD | -97.69% | |
| 0.00USD | -37.33% | |
| 0.00USD | -21.82% | |
| 0.00USD | +222.82% | |
| 0.00USD | +17,046.86% | |
| 0.00USD | — | |
| 0.00USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Forza Innovations Stock analysis
What does Forza Innovations do? Forza Innovations, Inc. generates revenue through the sale of its WarmUp product line, which includes the J4 Sport, J4 X, and J4 Fitbelt wearable back compression devices. These devices utilize carbon microfibers and rechargeable lithium batteries to provide therapeutic heat application, targeting stiff and sore muscles. The J4 Sport is designed for patients with chronic conditions like arthritis, osteoporosis, fibromyalgia, and ligament strains, while the J4 Fitbelt focuses on abdominal and lower back muscles or single muscle groups. The J4 Core supports users during physical activities, recovery, and daily routines.
The company's revenue streams are derived from direct sales of these therapeutic wearable devices to consumers seeking relief from muscle stiffness and inflammation. The WarmUp series targets health-conscious individuals and patients managing chronic pain conditions, positioning itself as a solution for both active lifestyles and medical needs. Products are sold under the WarmUp brand, with specific models catering to distinct user segments based on their therapeutic requirements.
Forza Innovations has acquired ownership of late developmental stage products, including the WarmUp line, which are now its primary revenue-generating assets. The company focuses on the health-tech wearable performance market, emphasizing the therapeutic benefits of heat application through its carbon microfiber technology. Sales are driven by the specific medical and wellness applications of each product model. Forza Innovations is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Forza Innovations stock
On Eulerpool you can find the complete historical development of Revenue per Share Forza Innovations since 2006 – with annual values, charts, and detailed analysis.
Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Forza Innovations
All Key Metrics — Forza Innovations
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth